Search
for
Sort by
Research 31–60 of 176
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
- Polycystic ovary syndrome and impact on health
- Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations
- Associaton of Insulin Resistance Linked Diseases and Hair Loss in Elderly Men. Finnish Population-based Study
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome
- UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Tumor Necrosis Factor-Alpha and Polycystic Ovarian Syndrome: A Clinical, Biochemical, and Molecular Genetic Study
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
- Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne
- Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment